Zealand Pharma A/S
ZEAL
Rank in Stocks
#5468
Zealand Pharma A/S is a Danish biotechnology firm dedicated to the... Zealand Pharma A/S is a Danish biotechnology firm dedicated to the identification, progression, and market introduction of peptide-based therapeutics. The company concentrates its efforts on treatments for gastrointestinal and metabolic ailments, as well as other specialized conditions where current medical options are insufficient. Its commercialized product, Dasiglucagon, is an injectable solution provided in a pre-filled syringe or autoinjector, used to address severe hypoglycemia. Furthermore, Zealand Pharma is actively developing Dasiglucagon for inclusion in bi-hormone artificial pancreas systems that integrate both insulin and dasiglucagon. The compound Dasiglucagon is also undergoing late-stage (Phase III) clinical trials for congenital hyperinsulinism. Another significant asset in its development pipeline is glepaglutide, a long-acting GLP-2 analog, which is likewise in Phase III clinical studies for treating short bowel syndrome. Founded in 1998 and headquartered in Copenhagen, Denmark, Zealand Pharma A/S maintains strategic alliances with a range of partners, including Sanofi-Aventis Deutschland GmbH, Boehringer Ingelheim International GmbH, Alexion Pharmaceuticals, Inc., and Beta Bionics, Inc.
Share Price
$35.95
Market Cap
$2.50B
Change (1 day)
2.44%
Change (1 year)
-49.80%
Country
DK
Trade Zealand Pharma A/S (ZEAL)
Category
Healthcare
Stock split history for Zealand Pharma A/S (ZEAL)
Zealand Pharma A/S stock (symbol: ZEAL) underwent a total of 0 stock splits.
The most recent stock split occurred on Oct 20, 2026.
One ZEAL share bought prior to Oct 20, 2026 would equal to 0 ZEAL shares today.
The most recent stock split occurred on Oct 20, 2026.
One ZEAL share bought prior to Oct 20, 2026 would equal to 0 ZEAL shares today.
Stock split list
| Year | Split | Multiple | Cumulative Multiple |
|---|---|---|---|
| Not enough data for the provided dates. | |||
Stock splits for similar companies or competitors
| Company | Number of stock splits | Cumulative Multiple | Country |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
CH
|
|
| 0 | - |
NL
|
